2021 Form 10-K Financial Statement
#000165495422004172 Filed on March 30, 2022
Income Statement
| Concept | 2021 | 2020 Q4 | 2020 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $6.016M | $1.110M | $5.584M |
| YoY Change | 7.73% | 0.91% | 30.77% |
| % of Gross Profit | |||
| Research & Development | $5.483M | $1.140M | $5.918M |
| YoY Change | -7.36% | -43.84% | -10.06% |
| % of Gross Profit | |||
| Depreciation & Amortization | $116.2K | $50.00K | $99.34K |
| YoY Change | 17.01% | 150.0% | 24.18% |
| % of Gross Profit | |||
| Operating Expenses | $11.50M | $2.250M | $11.50M |
| YoY Change | -0.03% | -28.12% | 6.11% |
| Operating Profit | -$11.50M | -$11.50M | |
| YoY Change | -0.03% | 6.11% | |
| Interest Expense | $0.00 | $0.00 | -$230.0K |
| YoY Change | -100.0% | -100.0% | -90.25% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $267.1K | $0.00 | -$223.6K |
| YoY Change | -219.44% | -100.0% | 103.26% |
| Pretax Income | -$11.23M | -$2.250M | -$11.73M |
| YoY Change | -4.22% | -53.22% | -11.9% |
| Income Tax | $0.00 | $0.00 | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$11.23M | -$2.250M | -$11.73M |
| YoY Change | -4.22% | -53.22% | -11.9% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | -$0.28 | -$0.63 | |
| Diluted Earnings Per Share | -$274.5K | -$421.3K | -$611.3K |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 | 2020 Q4 | 2020 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $9.462M | $7.230M | $7.230M |
| YoY Change | 30.86% | 17.18% | 17.18% |
| Cash & Equivalents | $7.227M | ||
| Short-Term Investments | |||
| Other Short-Term Assets | $1.348M | $5.986K | $400.0K |
| YoY Change | 237.0% | -97.61% | 60.0% |
| Inventory | $1.285M | $589.6K | $590.0K |
| Prepaid Expenses | $390.8K | ||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $12.09M | $8.208M | $8.210M |
| YoY Change | 47.31% | 25.5% | 25.54% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $774.5K | $212.2K | $550.0K |
| YoY Change | 40.83% | -66.84% | -14.06% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $5.990K | $5.986K | $10.00K |
| YoY Change | -40.1% | ||
| Total Long-Term Assets | $780.5K | $557.2K | $550.0K |
| YoY Change | 41.91% | -12.93% | -14.06% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $12.09M | $8.208M | $8.210M |
| Total Long-Term Assets | $780.5K | $557.2K | $550.0K |
| Total Assets | $12.87M | $8.765M | $8.760M |
| YoY Change | 46.97% | 22.07% | 22.01% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $791.1K | $402.9K | $400.0K |
| YoY Change | 97.76% | -68.52% | -68.75% |
| Accrued Expenses | $752.7K | $580.0K | $580.0K |
| YoY Change | 29.78% | 16.0% | 16.0% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% | |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.544M | $986.7K | $990.0K |
| YoY Change | 55.94% | -52.34% | -52.17% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $28.48K | $340.0K | $340.0K |
| YoY Change | -91.62% | ||
| Other Long-Term Liabilities | $518.2K | $270.0K | $270.0K |
| YoY Change | 91.91% | -20.59% | -20.59% |
| Total Long-Term Liabilities | $546.6K | $610.0K | $610.0K |
| YoY Change | -10.39% | 79.41% | 79.41% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.544M | $986.7K | $990.0K |
| Total Long-Term Liabilities | $546.6K | $610.0K | $610.0K |
| Total Liabilities | $2.090M | $1.596M | $1.600M |
| YoY Change | 30.65% | -34.06% | -33.88% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$57.34M | ||
| YoY Change | |||
| Common Stock | $3.404K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $10.78M | $7.169M | $7.170M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $12.87M | $8.765M | $8.760M |
| YoY Change | 46.97% | 22.07% | 22.01% |
Cashflow Statement
| Concept | 2021 | 2020 Q4 | 2020 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$11.23M | -$2.250M | -$11.73M |
| YoY Change | -4.22% | -53.22% | -11.9% |
| Depreciation, Depletion And Amortization | $116.2K | $50.00K | $99.34K |
| YoY Change | 17.01% | 150.0% | 24.18% |
| Cash From Operating Activities | -$11.12M | -$2.080M | -$10.75M |
| YoY Change | 3.5% | 8.9% | 25.11% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $45.00K | -$70.00K | $75.33K |
| YoY Change | -40.27% | 133.33% | -288.33% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$45.00K | -$70.00K | -$75.33K |
| YoY Change | -40.27% | 133.33% | 88.33% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $10.62M | $6.781M | |
| YoY Change | 56.56% | 16.11% | |
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $13.40M | 5.580M | $11.88M |
| YoY Change | 12.86% | -4.62% | 42.39% |
| NET CHANGE | |||
| Cash From Operating Activities | -$11.12M | -2.080M | -$10.75M |
| Cash From Investing Activities | -$45.00K | -70.00K | -$75.33K |
| Cash From Financing Activities | $13.40M | 5.580M | $11.88M |
| Net Change In Cash | $2.234M | 3.430M | $1.053M |
| YoY Change | 112.15% | -12.28% | -463.14% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$11.12M | -$2.080M | -$10.75M |
| Capital Expenditures | $45.00K | -$70.00K | $75.33K |
| Free Cash Flow | -$11.17M | -$2.010M | -$10.82M |
| YoY Change | 3.19% | 6.91% | 26.57% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021 | dei |
Auditor Location
AuditorLocation
|
New York, NY | |
| CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
42554514 | shares |
| CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34049704 | shares |
| CY2021 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1075376 | USD |
| CY2020 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
581893 | USD |
| CY2021Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
5750 | USD |
| CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4940398 | USD |
| CY2020 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5002080 | USD |
| CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
11498305 | USD |
| CY2020 | us-gaap |
Operating Expenses
OperatingExpenses
|
11501917 | USD |
| CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11498305 | USD |
| CY2020 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11501917 | USD |
| CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2020 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
232426 | USD |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4760670 | USD |
| CY2020 | ndra |
Series A Convertible Preferred Stock Converted To Common Stock Amount
SeriesAConvertiblePreferredStockConvertedToCommonStockAmount
|
0 | USD |
| CY2020 | ndra |
Series B Convertible Preferred Stock Converted To Common Stock Amount
SeriesBConvertiblePreferredStockConvertedToCommonStockAmount
|
0 | USD |
| CY2020 | ndra |
Common Stock Issued For Cash Net Of Funding Costs Amount
CommonStockIssuedForCashNetOfFundingCostsAmount
|
6780942 | USD |
| CY2020 | ndra |
Common Stock Issued For Note Conversions Amount
CommonStockIssuedForNoteConversionsAmount
|
493847 | USD |
| CY2020 | ndra |
Common Stock Issued For Warrant Exercise Amount
CommonStockIssuedForWarrantExerciseAmount
|
4757011 | USD |
| CY2020 | ndra |
Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
|
125501 | USD |
| CY2020 | ndra |
Common Stock Issued For Rsu Amount
CommonStockIssuedForRsuAmount
|
453790 | USD |
| CY2020 | ndra |
Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
|
1523061 | USD |
| CY2020 | ndra |
Fair Value Adjustment Related To Warrants Repricing
FairValueAdjustmentRelatedToWarrantsRepricing
|
0 | USD |
| CY2020 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | USD |
| CY2020 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11725501 | USD |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7169322 | USD |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7169322 | USD |
| CY2021 | ndra |
Deemed Dividend
DeemedDividend
|
0 | USD |
| CY2021 | ndra |
Common Stock Issued For Cash Net Of Funding Costs Amount
CommonStockIssuedForCashNetOfFundingCostsAmount
|
10615975 | USD |
| CY2021 | ndra |
Common Stock Issued For Warrant Exercise Amount
CommonStockIssuedForWarrantExerciseAmount
|
2785627 | USD |
| CY2021 | ndra |
Series A Convertible Preferred Stock Converted To Common Stock Amount
SeriesAConvertiblePreferredStockConvertedToCommonStockAmount
|
0 | USD |
| CY2021 | ndra |
Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
|
1334112 | USD |
| CY2021 | ndra |
Common Stock Issued For Option Exercise Amount
CommonStockIssuedForOptionExerciseAmount
|
0 | USD |
| CY2021 | ndra |
Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
|
74000 | USD |
| CY2021 | ndra |
Common Stock Issued For Rsu Amount
CommonStockIssuedForRsuAmount
|
36460 | USD |
| CY2021 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
0 | USD |
| CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11231250 | USD |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10784246 | USD |
| CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
11231250 | USD |
| CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
11725501 | USD |
| CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
116238 | USD |
| CY2020 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
99342 | USD |
| CY2021 | ndra |
Fixed Assets Write Off
FixedAssetsWriteOff
|
9874 | USD |
| CY2020 | ndra |
Fixed Assets Write Off
FixedAssetsWriteOff
|
0 | USD |
| CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1444572 | USD |
| CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2102352 | USD |
| CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD |
| CY2020 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
232426 | USD |
| CY2021 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
108177 | USD |
| CY2020 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
65907 | USD |
| CY2021 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
308600 | USD |
| CY2020 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
| CY2021 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
957203 | USD |
| CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
694958 | USD |
| CY2021 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
0 | USD |
| CY2020 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-124715 | USD |
| CY2020 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-834990 | USD |
| CY2021 | ndra |
Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
|
-100338 | USD |
| CY2020 | ndra |
Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
|
-60617 | USD |
| CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10746595 | USD |
| CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
75333 | USD |
| CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-75333 | USD |
| CY2021 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2785627 | USD |
| CY2020 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
4757011 | USD |
| CY2021 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
0 | USD |
| CY2020 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
337084 | USD |
| CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
10615975 | USD |
| CY2020 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
6780942 | USD |
| CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13401602 | USD |
| CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11875037 | USD |
| CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
2234218 | USD |
| CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
1053109 | USD |
| CY2020Q4 | us-gaap |
Cash
Cash
|
7227316 | USD |
| CY2019Q4 | us-gaap |
Cash
Cash
|
6174207 | USD |
| CY2021Q4 | us-gaap |
Cash
Cash
|
9461534 | USD |
| CY2020Q4 | us-gaap |
Cash
Cash
|
7227316 | USD |
| CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
57655 | USD |
| CY2020 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1920 | USD |
| CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2020 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2021 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
| CY2020 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
493814 | USD |
| CY2021 | ndra |
Exchange Of Balance In Convertible Notes And Accrued Interest For Series Preferred Stock
ExchangeOfBalanceInConvertibleNotesAndAccruedInterestForSeriesPreferredStock
|
0 | USD |
| CY2020 | ndra |
Exchange Of Balance In Convertible Notes And Accrued Interest For Series Preferred Stock
ExchangeOfBalanceInConvertibleNotesAndAccruedInterestForSeriesPreferredStock
|
0 | USD |
| CY2021 | us-gaap |
Dividends
Dividends
|
121071 | USD |
| CY2021 | ndra |
Conversion Of Series A Convertible Preferred Stock
ConversionOfSeriesAConvertiblePreferredStock
|
-7 | USD |
| CY2021 | ndra |
Conversion Of Series B Convertible Preferred Stock
ConversionOfSeriesBConvertiblePreferredStock
|
0 | USD |
| CY2020 | ndra |
Conversion Of Series B Convertible Preferred Stock
ConversionOfSeriesBConvertiblePreferredStock
|
-36 | USD |
| CY2021 | ndra |
Stock Issued For Financing Cost
StockIssuedForFinancingCost
|
0 | USD |
| CY2020 | ndra |
Stock Issued For Financing Cost
StockIssuedForFinancingCost
|
27300 | USD |
| CY2021 | ndra |
Stock Dividend Payable
StockDividendPayable
|
-3067 | USD |
| CY2020 | ndra |
Stock Dividend Payable
StockDividendPayable
|
-49649 | USD |
| CY2021 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
643413 | USD |
| CY2020 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
339012 | USD |
| CY2021 | ndra |
Lease Liability
LeaseLiability
|
650477 | USD |
| CY2020 | ndra |
Lease Liability
LeaseLiability
|
348388 | USD |
| CY2021 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Note 1 – Nature of the Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">ENDRA Life Sciences Inc. (“ENDRA” or the “Company”) has developed and is continuing to develop technology for increasing the capabilities of clinical diagnostic ultrasound to broaden patient access to the safe diagnosis and treatment of a number of significant medical conditions in circumstances where expensive X-ray computed tomography (“CT”) and magnetic resonance imaging (“MRI”) technology is unavailable or impractical.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">ENDRA was incorporated on July 18, 2007 as a Delaware corporation.</p> | |
| CY2021 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Management makes estimates that affect certain accounts including deferred income tax assets, accrued expenses, fair value of equity instruments and reserves for any other commitments or contingencies. Any adjustments applied to estimates are recognized in the period in which such adjustments are determined.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The COVID-19 outbreak, which the World Health Organization has classified as a pandemic, has prompted governments and regulatory bodies throughout the world to issue “stay-at-home” or similar orders, and enact restrictions on the performance of “non-essential” services, public gatherings and travel.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of December 31, 2021 and through the date of the filing of this Annual Report on Form 10-K. The accounting matters assessed included, but were not limited to, estimates related to the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and assessments of impairment related to long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">Despite the Company’s efforts, the ultimate impact of COVID-19 on the Company’s business depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</p> | |
| CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
650477 | USD |
| CY2020Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
348388 | USD |
| CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
643413 | USD |
| CY2020Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
339012 | USD |
| CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5482531 | USD |
| CY2020 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5917944 | USD |
| CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7848899 | shares |
| CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10047010 | shares |
| CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
10047010 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
|
On January 1, 2022, the pool of shares available for issuance under the Omnibus Plan automatically increased by 1,622,848 shares from 7,461,228 shares to 9,084,076 | |
| CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-68690810 | USD |
| CY2021Q4 | us-gaap |
Assets Net
AssetsNet
|
10550348 | USD |
| CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
1284578 | USD |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
589620 | USD |
| CY2021Q4 | us-gaap |
Capital Units Authorized
CapitalUnitsAuthorized
|
90000000 | shares |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
605248 | USD |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
718902 | USD |
| CY2021Q4 | us-gaap |
Development In Process
DevelopmentInProcess
|
107682 | USD |
| CY2020Q4 | us-gaap |
Development In Process
DevelopmentInProcess
|
79207 | USD |
| CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
581800 | USD |
| CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
585867 | USD |
| CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
131130 | USD |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
212242 | USD |
| CY2021 | us-gaap |
Depreciation
Depreciation
|
116238 | USD |
| CY2020 | us-gaap |
Depreciation
Depreciation
|
99342 | USD |
| CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
791052 | USD |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
402910 | USD |
| CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
101459 | USD |
| CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
48260 | USD |
| CY2021Q4 | us-gaap |
Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
|
396043 | USD |
| CY2020Q4 | us-gaap |
Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
|
369393 | USD |
| CY2020Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
5750 | USD |
| CY2021Q4 | us-gaap |
Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
|
117133 | USD |
| CY2020Q4 | us-gaap |
Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
|
83870 | USD |
| CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1411437 | USD |
| CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
910183 | USD |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
| CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
42554514 | shares |
| CY2021Q4 | ndra |
Stock Payable Share
StockPayableShare
|
13863 | USD |
| CY2021 | ndra |
Total Common Stock Shares Issued
TotalCommonStockSharesIssued
|
8504810 | USD |
| CY2021 | ndra |
Proceeds From Sales Of Common Stock Shares Return
ProceedsFromSalesOfCommonStockSharesReturn
|
4586958 | shares |
| CY2021 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
10615975 | USD |
| CY2021 | ndra |
Common Stock Shares Upon Warrat Exercise Shares
CommonStockSharesUponWarratExerciseShares
|
3567899 | shares |
| CY2021 | ndra |
Common Stock Shares Upon Warrat Exercise Amount
CommonStockSharesUponWarratExerciseAmount
|
2785627 | USD |
| CY2021 | ndra |
Common Stock Shares Upon Cashless Warrant Exercise
CommonStockSharesUponCashlessWarrantExercise
|
202887 | shares |
| CY2021 | ndra |
Common Stock Shares Upon Cashless Option Exercise
CommonStockSharesUponCashlessOptionExercise
|
23835 | shares |
| CY2021 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
32527 | shares |
| CY2021 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
74000 | USD |
| CY2021 | ndra |
Common Stock Share Issued For Rsus Shares
CommonStockShareIssuedForRsusShares
|
22815 | shares |
| CY2021 | ndra |
Common Stock Share Issued For Rsus Amount
CommonStockShareIssuedForRsusAmount
|
36460 | USD |
| CY2020 | ndra |
Total Common Stock Shares Issued
TotalCommonStockSharesIssued
|
25628303 | USD |
| CY2020Q4 | ndra |
Number Of Shares Underwritten Offering
NumberOfSharesUnderwrittenOffering
|
7857286 | shares |
| CY2020Q4 | ndra |
Net Proceeds Underwritten Offering
NetProceedsUnderwrittenOffering
|
5000192 | USD |
| CY2020 | ndra |
Common Stock Shares Upon Warrat Exercise Shares
CommonStockSharesUponWarratExerciseShares
|
7098108 | shares |
| CY2020 | ndra |
Common Stock Shares Upon Warrat Exercise Amount
CommonStockSharesUponWarratExerciseAmount
|
4757011 | USD |
| CY2020 | ndra |
Proceeds From Sales Of Common Stock Shares Return
ProceedsFromSalesOfCommonStockSharesReturn
|
2005491 | shares |
| CY2020 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
1780750 | USD |
| CY2019Q3 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
331441 | shares |
| CY2019Q3 | ndra |
Conversion Of Principal And Accrued Interest On Convertible Promissory Notes Issued
ConversionOfPrincipalAndAccruedInterestOnConvertiblePromissoryNotesIssued
|
493847 | USD |
| CY2020 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
149025 | shares |
| CY2020 | ndra |
Common Stock Share Issued For Rsus Shares
CommonStockShareIssuedForRsusShares
|
648273 | shares |
| CY2021 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
25513 | USD |
| CY2021 | ndra |
Aggregate Fair Value Of Stock Options Granted
AggregateFairValueOfStockOptionsGranted
|
3783454 | USD |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
|
0 | pure |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3569707 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.13 | |
| CY2021 | ndra |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y6M | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1832000 | shares |
| CY2020Q2 | ndra |
Closing Price
ClosingPrice
|
0.70 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
22815 | shares |
| CY2021Q1 | ndra |
Total Fair Value Of Restricted Stock Unit
TotalFairValueOfRestrictedStockUnit
|
45858 | USD |
| CY2021Q1 | ndra |
Closing Price
ClosingPrice
|
2.01 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.36 | |
| CY2021 | ndra |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
|
P9Y1M13D | |
| CY2021 | ndra |
Number Of Options Exercised
NumberOfOptionsExercised
|
-37645 | shares |
| CY2021 | ndra |
Number Of Options Cancelled Or Expired
NumberOfOptionsCancelledOrExpired
|
-114852 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.21 | |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y5M1D | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
2.37 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
674019 | shares |
| CY2020 | ndra |
Restricted Stock Units Granted To Management Vested
RestrictedStockUnitsGrantedToManagementVested
|
461146 | shares |
| CY2020Q4 | ndra |
Restricted Stock Units Granted Equal Quarterly Installments
RestrictedStockUnitsGrantedEqualQuarterlyInstallments
|
212873 | shares |
| CY2020Q2 | ndra |
Total Fair Value Of Restricted Stock Unit
TotalFairValueOfRestrictedStockUnit
|
471813 | USD |
| CY2021 | ndra |
Aggregate Gross Proceeds From Issuance Of Common Stock Shares
AggregateGrossProceedsFromIssuanceOfCommonStockShares
|
12600000 | USD |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y1M9D | |
| CY2021 | ndra |
Common Stock Upon The Exercise Of Private Warrants
CommonStockUponTheExerciseOfPrivateWarrants
|
common stock upon the exercise of Private Warrants greater than 19.99% of the number of shares outstanding prior to any such issuance | |
| CY2021 | ndra |
Common Stock Share Issued Upon Private Warrant Exercises Shares
CommonStockShareIssuedUponPrivateWarrantExercisesShares
|
3567899 | shares |
| CY2021 | ndra |
Common Stock Share Issued Upon Private Warrant Exercises Amount
CommonStockShareIssuedUponPrivateWarrantExercisesAmount
|
2785626 | USD |
| CY2021 | ndra |
Common Stock Shares Upon Cashless Warrant Exercise
CommonStockSharesUponCashlessWarrantExercise
|
202887 | shares |
| CY2020 | ndra |
Common Stock Share Issued Upon Private Warrant Exercises Shares
CommonStockShareIssuedUponPrivateWarrantExercisesShares
|
7098108 | shares |
| CY2020 | ndra |
Common Stock Share Issued Upon Private Warrant Exercises Amount
CommonStockShareIssuedUponPrivateWarrantExercisesAmount
|
4757011 | USD |
| CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
190963 | USD |
| CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
196721 | USD |
| CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
202624 | USD |
| CY2021Q4 | ndra |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
202624 | USD |
| CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
792932 | USD |
| CY2021Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
142455 | USD |
| CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
650477 | USD |
| CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
132330 | USD |
| CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
518147 | USD |
| CY2021 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
178620 | USD |
| CY2020 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
120275 | USD |
| CY2019Q2 | ndra |
Percentageof Bonusonbasicsalary
PercentageofBonusonbasicsalary
|
0.30 | pure |
| CY2021 | ndra |
Effective Income Tax Rate Reconciliation State Income Tax Net Of Federal Benefit Amount
EffectiveIncomeTaxRateReconciliationStateIncomeTaxNetOfFederalBenefitAmount
|
-411900 | USD |
| CY2021 | ndra |
Effective Income Tax Rate Reconciliation State Income Tax Net Of Federal Benefit Percentage
EffectiveIncomeTaxRateReconciliationStateIncomeTaxNetOfFederalBenefitPercentage
|
0.04 | pure |
| CY2020 | ndra |
Effective Income Tax Rate Reconciliation State Income Tax Net Of Federal Benefit Amount
EffectiveIncomeTaxRateReconciliationStateIncomeTaxNetOfFederalBenefitAmount
|
319800 | USD |
| CY2021 | ndra |
Effectiveincometaxratereconciliationpermanent Differences Percentage
EffectiveincometaxratereconciliationpermanentDifferencesPercentage
|
-0.02 | pure |
| CY2020 | ndra |
Effectiveincometaxratereconciliationpermanent Differences Percentage
EffectiveincometaxratereconciliationpermanentDifferencesPercentage
|
0 | pure |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.07 | pure |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0 | pure |
| CY2021 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-43700 | USD |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0 | pure |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0 | pure |
| CY2021 | ndra |
Schedule Of Components Of Earnings Before Income Taxes Table Textblock
ScheduleOfComponentsOfEarningsBeforeIncomeTaxesTableTextblock
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For the Years Ended December 31,</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><em>Income (loss) before income taxes</em></strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Domestic</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(10,030,200</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(11,725,500</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Foreign</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(1,201,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total income (loss) before income taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(11,231,200</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(11,725,500</td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table> | |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-10030200 | USD |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-11725500 | USD |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-1201000 | USD |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
0 | USD |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-11231200 | USD |
| CY2020 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-11725500 | USD |
| CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-2358500 | USD |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
| CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-2462400 | USD |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
| CY2021 | ndra |
Effective Income Tax Rate Reconciliation Permanent Differences Amount
EffectiveIncomeTaxRateReconciliationPermanentDifferencesAmount
|
280200 | USD |
| CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
| CY2020 | ndra |
Effective Income Tax Rate Reconciliation State Income Tax Net Of Federal Benefit Percentage
EffectiveIncomeTaxRateReconciliationStateIncomeTaxNetOfFederalBenefitPercentage
|
-0.03 | pure |
| CY2021 | ndra |
Effective Income Tax Rate Reconciliation State Rate Change Federal Impact Amount
EffectiveIncomeTaxRateReconciliationStateRateChangeFederalImpactAmount
|
171600 | USD |
| CY2021 | ndra |
Effective Income Tax Rate Reconciliation State Rate Change Federal Impact Percentage
EffectiveIncomeTaxRateReconciliationStateRateChangeFederalImpactPercentage
|
-0.02 | pure |
| CY2020 | ndra |
Effective Income Tax Rate Reconciliation State Rate Change Federal Impact Percentage
EffectiveIncomeTaxRateReconciliationStateRateChangeFederalImpactPercentage
|
0 | pure |
| CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-817300 | USD |
| CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
2117100 | USD |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.19 | pure |
| CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
2142600 | USD |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.18 | pure |
| CY2021 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
1062500 | USD |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
-0.09 | pure |
| CY2020 | us-gaap |
Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
|
0 | pure |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
471000 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
150600 | USD |
| CY2021Q4 | ndra |
Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
|
49300 | USD |
| CY2020Q4 | ndra |
Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
|
0 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
0 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
|
396100 | USD |
| CY2021Q4 | ndra |
Deferred Tax Right Of Use Asste
DeferredTaxRightOfUseAsste
|
-169600 | USD |
| CY2020Q4 | ndra |
Deferred Tax Right Of Use Asste
DeferredTaxRightOfUseAsste
|
0 | USD |
| CY2021Q4 | ndra |
Deferred Tax Right Of Use Liability
DeferredTaxRightOfUseLiability
|
171100 | USD |
| CY2020Q4 | ndra |
Deferred Tax Right Of Use Liability
DeferredTaxRightOfUseLiability
|
0 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
12580100 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
10734000 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
295900 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13397800 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11280700 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13397800 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11280700 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
| CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
51240386 | USD |
| CY2021Q4 | ndra |
Net Operating Loss Carryforward Begain To Expire
NetOperatingLossCarryforwardBegainToExpire
|
16012698 | USD |
| CY2021 | us-gaap |
Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
|
35106617 | USD |
